Fibrillin 2 (FBN2)
CCA; DA9; FBLN2; Congenital Contractural Arachnodactyly; Fibrillin 5
Using the partial FBN2 cDNA isolated by Lee et al. (1991) to screen an MG-63 human osteosarcoma cell line cDNA library, Zhang et al. (1994) obtained a full-length FBN2 clone. The deduced 2,889-amino acid protein contains an N-terminal signal peptide, followed by a proline-rich region, 3 tandem N-terminal EGF-like repeats, and 41 calcium-binding EGF-like repeats interspersed with another EGF-like repeat, a glycine-rich region, 7 TGF-binding protein repeats, and 2 Fib motifs.
FBN2 also has 2 potential cell attachment sequences, multiple N-glycosylation sites, and 2 C-terminal polylysine stretches. The structures of FBN2 and FBN1 are highly similar, with the most significant difference being the glycine-rich sequence near the N terminus of FBN2, where FBN1 has a proline-rich sequence.
Organism species: Homo sapiens (Human)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Hu01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Hu01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Hu01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Hu01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Hu01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Mus musculus (Mouse)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Mu01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Mu01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Mu01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Mu01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Mu01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Rattus norvegicus (Rat)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Ra01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Ra01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Ra01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Ra01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Ra01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Canis familiaris; Canine (Dog)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Ca01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Ca01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Ca01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Ca01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Ca01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Sus scrofa; Porcine (Pig)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Po01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Po01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Po01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Po01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Po01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Bos taurus; Bovine (Cattle)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Bo01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Bo01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Bo01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Bo01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Bo01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Oryctolagus cuniculus (Rabbit)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Rb01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Rb01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Rb01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Rb01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Rb01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Organism species: Rhesus monkey (Simian)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | RPW434Mo01 | Recombinant Fibrillin 2 (FBN2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAW434Mo01 | Monoclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IP. |
PAW434Mo01 | Polyclonal Antibody to Fibrillin 2 (FBN2) | WB; IHC; ICC; IF. | |
Assay Kits | CLW434Mo01 | CLIA Kit for Fibrillin 2 (FBN2) | CLIA assay for Antigen Detection |
ELW434Mo01 | ELISA Kit for Fibrillin 2 (FBN2) | Enzyme-linked immunosorbent assay for Antigen Detection |
Reference
"Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices."
J. Cell Biol. 124:855-863(1994) [PubMed] [Europe PMC] [Abstract]
"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
"The DNA sequence and comparative analysis of human chromosome 5."
Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract]
"Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes."
Nature 352:330-334(1991) [PubMed] [Europe PMC] [Abstract]
"Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
"Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration."
Hum. Mol. Genet. 23:5827-5837(2014) [PubMed] [Europe PMC] [Abstract]
"Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly."
Nat. Genet. 11:456-458(1995) [PubMed] [Europe PMC] [Abstract]
"Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development."
Am. J. Med. Genet. 78:350-355(1998) [PubMed] [Europe PMC] [Abstract]
"A single mutation that results in an Asp-to-His substitution and partial exon skipping in a family with congenital contractural arachnodactyly."
Hum. Genet. 103:22-28(1998) [PubMed] [Europe PMC] [Abstract]
"Two novel fibrillin-2 mutations in congenital contractural arachnodactyly."
Am. J. Med. Genet. 92:7-12(2000) [PubMed] [Europe PMC] [Abstract]
"Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype."
Hum. Mutat. 19:39-48(2002) [PubMed] [Europe PMC] [Abstract]
"Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature."
Hum. Mutat. 30:334-341(2009) [PubMed] [Europe PMC] [Abstract]
"Evidence for a recurrent microdeletion at chromosome 16p11.2 associated with congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung disease."
Am. J. Med. Genet. A 152A:2618-2622(2010) [PubMed] [Europe PMC] [Abstract]
"Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma."
Nature 469:539-542(2011) [PubMed] [Europe PMC] [Abstract]